ArticleBritish journal of pharmacology2020

The enhanced immunopharmacology of VIB4920, a novel Tn3 fusion protein and CD40L antagonist, and assessment of its safety profile in cynomolgus monkeys.

Simone M Nicholson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.